Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dualis: Switching to Dual Therapy in HIV
NCT02486133Phase 3Completed
- Sponsor
- Technical University of Munich
- Start
- Jul 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dolutegravir in human immunodeficiency virus infection (HIV), sponsored by Technical University of Munich. Started Jul 2015; status: completed.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02486133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486133.